What is Curative Biotechnology Inc (CUBT) stock price today?

Curative Biotechnology Inc (CUBT) currently trades at $0.94 per share. The stock has a market capitalization of $1.07B and a P/E ratio of —x.

Is CUBT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Curative Biotechnology Inc has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Curative Biotechnology Inc's revenue and earnings?

Curative Biotechnology Inc has trailing twelve-month (TTM) revenue of $132320.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.72.

CUBT

Curative Biotechnology Inc

NYSE MKT: CUBT · HEALTHCARE · BIOTECHNOLOGY

$0.94

+0.00% today

Updated 2026-04-29

Market cap

$1.07B

P/E ratio

—

P/S ratio

158.53x

EPS (TTM)

$-0.72

Dividend yield

—

52W range

$0 – $1

Volume

0.1M

Market cap

$1.07B

P/E ratio

—

P/S ratio

158.53x

EPS (TTM)

$-0.72

Dividend yield

—

52W range

$0 – $1

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$—

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-185272.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	—	—	$132320.00
Net income	$-5.34M	$-5.38M	$-3.96M	$-3.56M	$-482000.00
EPS	—	—	—	—	$-0.72
Free cash flow	$-1.63M	$-1.61M	$-500626.00	$-1.02M	$-185272.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CUBT	$1.07B	17	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Curative Biotechnology Inc trades at $0.94. Our Smart Value Score of 17/100 indicates the stock is weak. TTM revenue stands at $132320.00.

Frequently asked questions

What is Curative Biotechnology Inc's stock price?

Curative Biotechnology Inc (CUBT) trades at $0.94.

Is Curative Biotechnology Inc overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Curative Biotechnology Inc (CUBT)?

The analyst target price is $—, representing NaN% downside from the current price of $0.94.

What is Curative Biotechnology Inc's revenue?

TTM revenue is $132320.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNYSE MKT

CurrencyUSD

Quick metrics

P/S ratio158.53x

ROE-3.98%

Beta1.42

50D MA$0.03

200D MA$0.01

Shares out1.05B

Float0.86B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CUBT vs LLY →CUBT vs JNJ →CUBT vs ABBV →Stock screener →